BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22092650)

  • 1. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
    Fabi SG; Peterson JD; Goldman MP; Guiha I
    Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.
    Peterson JD; Goldman MP
    Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant endothelin release in patients treated with foam sclerotherapy.
    Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
    Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects.
    Palm MD; Guiha IC; Goldman MP
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1026-33. PubMed ID: 20590709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.
    Beckitt T; Elstone A; Ashley S
    Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):115-9. PubMed ID: 21531588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
    Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
    Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of symptomatic high-flow female varicoceles with stop-flow foam sclerotherapy.
    Gandini R; Konda D; Abrignani S; Chiocchi M; Da Ros V; Morosetti D; Simonetti G
    Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1259-67. PubMed ID: 24190634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
    Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
    J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate--outcome in 244 patients.
    Gandini R; Konda D; Reale CA; Pampana E; Maresca L; Spinelli A; Stefanini M; Simonetti G
    Radiology; 2008 Feb; 246(2):612-8. PubMed ID: 18227549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy in the management of varicose veins and its dermatological complications.
    Subbarao NT; Aradhya SS; Veerabhadrappa NH
    Indian J Dermatol Venereol Leprol; 2013; 79(3):383-8. PubMed ID: 23619443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm.
    Barrett JM; Allen B; Ockelford A; Goldman MP
    Dermatol Surg; 2004 Nov; 30(11):1386-90. PubMed ID: 15522019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological and chest symptoms following sclerotherapy: a single centre experience.
    Hill DA
    Phlebology; 2014 Oct; 29(9):619-27. PubMed ID: 23945346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopic sclerotherapy of ileal varices.
    Varanasi RV; Fleisher AS; Darwin PE; King CE; Haluszka O
    Gastrointest Endosc; 2000 Jul; 52(1):109-11. PubMed ID: 10882977
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol.
    Goldman MP
    Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
    Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.